Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
cancer
2
×
life sciences
2
×
national
national blog main
national top stories
san francisco blog main
san francisco top stories
arena pharmaceuticals
biotech
boulder/denver blog main
boulder/denver top stories
cardiovascular disease
clinical trials
colorectal cancer
crispr
crispr therapeutics
crispr-cas9
detroit blog main
detroit top stories
editas
editas medicine
eisai
europe blog main
europe top stories
fda
indiana blog main
indiana top stories
intellia therapeutics
lorcaserin
lung cancer
new york blog main
new york top stories
obsesity
orexigen therapeutics
p53
pancreatic cancer
product recalls
raleigh-durham blog main
What
cancer
2
×
medicine
risks
2
×
cas
cells
crispr
defect
drive
drug
edited
editing
eisai
fda
fears
flag
flags
gene
genetic
guardian
higher
human
incidence
known
lab
lorcaserin
loss
malfunction
market
marketing
nature
new
nicknamed
occurs
papers
patients
post
potential
published
pulls
raising
Language
unset
Current search:
cancer
×
" life sciences "
×
cancer
×
risks
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
6 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells